When should we order a next generation sequencing test in a patient with cancer?
Technical advances in genome sequencing and the implementation of next-generation sequencing (NGS) in clinical oncology have paved the way for individualizing cancer patient therapy based on molecular profiles. When and how to use NGS testing in the clinic is at present an unsolved issue, although n...
Main Authors: | Ramon Colomer, Rebeca Mondejar, Nuria Romero-Laorden, Arantzazu Alfranca, Francisco Sanchez-Madrid, Miguel Quintela-Fandino |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537020302315 |
Similar Items
-
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgementResearch in context
by: Ramon Colomer, et al.
Published: (2023-06-01) -
Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
by: Matthew G. Davey, et al.
Published: (2022-08-01) -
MicroRNA Expression Profiles and Breast Cancer Chemotherapy
by: Matthew G. Davey, et al.
Published: (2021-10-01) -
Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
by: Yuan Xue, et al.
Published: (2016-03-01) -
Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?
by: Veronique G. LeBlanc, et al.
Published: (2015-09-01)